Toll-like receptor 2 confers partial neuroprotection during prion disease.

Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. T...

Full description

Bibliographic Details
Main Authors: James A Carroll, Brent Race, Katie Williams, Bruce Chesebro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0208559
_version_ 1818588931288989696
author James A Carroll
Brent Race
Katie Williams
Bruce Chesebro
author_facet James A Carroll
Brent Race
Katie Williams
Bruce Chesebro
author_sort James A Carroll
collection DOAJ
description Neuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection.
first_indexed 2024-12-16T09:32:35Z
format Article
id doaj.art-9c73cd3201ab40c2ad32d80732ee0bec
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T09:32:35Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9c73cd3201ab40c2ad32d80732ee0bec2022-12-21T22:36:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020855910.1371/journal.pone.0208559Toll-like receptor 2 confers partial neuroprotection during prion disease.James A CarrollBrent RaceKatie WilliamsBruce ChesebroNeuroinflammation and neurodegeneration are common during prion infection, but the mechanisms that underlie these pathological features are not well understood. Several components of innate immunity, such as Toll-like receptor (TLR) 4 and Complement C1q, have been shown to influence prion disease. To identify additional components of innate immunity that might impact prion disease within the central nervous system (CNS), we screened RNA from brains of pre-clinical and clinical 22L-infected mice for alterations in genes associated with innate immunity. Transcription of several genes encoding damage-associated molecular pattern (DAMP) proteins and receptors were increased in the brains of prion-infected mice. To investigate the role of some of these proteins in prion disease of the CNS, we infected mice deficient in DAMP receptor genes Tlr2, C3ar1, and C5ar1 with 22L scrapie. Elimination of TLR2 accelerated disease by a median of 10 days, while lack of C3aR1 or C5aR1 had no effect on disease tempo. Histopathologically, all knockout mouse strains tested were similar to infected control mice in gliosis, vacuolation, and PrPSc deposition. Analysis of proinflammatory markers in the brains of infected knockout mice indicated only a few alterations in gene expression suggesting that C5aR1 and TLR2 signaling did not act synergistically in the brains of prion-infected mice. These results indicate that signaling through TLR2 confers partial neuroprotection during prion infection.https://doi.org/10.1371/journal.pone.0208559
spellingShingle James A Carroll
Brent Race
Katie Williams
Bruce Chesebro
Toll-like receptor 2 confers partial neuroprotection during prion disease.
PLoS ONE
title Toll-like receptor 2 confers partial neuroprotection during prion disease.
title_full Toll-like receptor 2 confers partial neuroprotection during prion disease.
title_fullStr Toll-like receptor 2 confers partial neuroprotection during prion disease.
title_full_unstemmed Toll-like receptor 2 confers partial neuroprotection during prion disease.
title_short Toll-like receptor 2 confers partial neuroprotection during prion disease.
title_sort toll like receptor 2 confers partial neuroprotection during prion disease
url https://doi.org/10.1371/journal.pone.0208559
work_keys_str_mv AT jamesacarroll tolllikereceptor2conferspartialneuroprotectionduringpriondisease
AT brentrace tolllikereceptor2conferspartialneuroprotectionduringpriondisease
AT katiewilliams tolllikereceptor2conferspartialneuroprotectionduringpriondisease
AT brucechesebro tolllikereceptor2conferspartialneuroprotectionduringpriondisease